pharma · Acute Myeloid Leukemia · Acute Leukemia · ATNM
Actinium Pharmaceuticals
Actinium Pharmaceuticals patent portfolio — 20 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- New York, USA
- Founded
- 2000
- Employees
- 58
- Programs
- 8
- Drugs
- 4
- Patents
- 20
Actinium Pharmaceuticals patents
20 pharmaceutical patents indexed for Actinium Pharmaceuticals. 1 expire within 24 months.
Actinium Pharmaceuticals has 20 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12410249
Low dose antibody-based methods for treating hematologic malignancies
granted -
US 12133849
Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha- emitting radioimmunotherapeutic
granted -
US 12083192
Methods for treatment of patients with myelodysplastic syndromes
granted -
US 11981741
Humanized anti-CD45 antibodies
granted -
US 11975081
Bifunctional chelators and conjugates
granted -
US 11964948
Bifunctional chelators and conjugates
granted -
US 11912780
Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies
granted -
US 11844799
Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic
granted -
US 11406724
Stabilized radiolabeled anti-CD45 immunoglobulin compositions
granted -
US 11364235
Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic
granted -
US 11292835
Low dose antibody-based methods for treating hematologic malignancies
granted -
US 11241512
Stabilized radio-labeled anti-CD45 immunoglobulin compositions
granted -
US 10736975
Infusion administration of conjugated monoclonal antibodies
granted -
US 10420851
Stabilized radiolabeled anti-CD45 immunoglobulin compositions
granted -
US 9790573
Method for purification of 225AC from irradiated 226RA-targets
granted -
US 9603954
Methods for generating radioimmunoconjugates
granted -
US 9534277
Method for purification of 225AC from irradiated 226RA-targets
granted -
US 8349391
Radium target and method for producing it
granted -
US 7374936
Method and means for site directed therapy
granted -
US 6403771
Method and means for site directed therapy
expired
Frequently asked questions
How many patents does Actinium Pharmaceuticals have?
20 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Actinium Pharmaceuticals patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.